🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to find out if removing a specific type of whi...
Status
Terminated
Location
Memorial SloanKettering Cancer Center
Start Date
2018-07-23
Trial ID
NCT03615144
RATIONALE: Chemotherapy, such as busulfan, melphalan, and thiotepa, may des...
Status
Completed
Location
Knight Cancer Institute at Oregon Health and Science University
Start Date
2005-03
Trial ID
NCT00238433
This study compares haplo-identical family donor stem cell transplantation ...
Status
Terminated
Location
Medical University of Vienna
Start Date
2019-11-12
Trial ID
NCT04067180
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Herbert Irving Comprehensive Cancer Center
Start Date
1996-05
Trial ID
NCT00008203
This study aims to evaluate the safety, feasibility, and preliminary effica...
Status
Not Yet Recruiting
Location
Institute of Hematology & Blood Diseases Hospital, China
Start Date
2026-08-01
Trial ID
NCT07757685
Treatments Being Tested
SIR-POSA is a phase II trial of peripheral blood stem cell (PBSC) transplan...
Status
Completed
Location
Ospedale San Raffaele
Start Date
2018-06-18
Trial ID
NCT03434704
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
1992-10
Trial ID
NCT00002515
The goal of this clinical trial is to learn if a combined treatment approac...
Status
Recruiting
Location
2nd Affiliated Hospital, School of Medicine
Start Date
2025-04-01
Trial ID
NCT07193654
This phase I trial tests the effect of allogeneic Orca-Q stem cell transpla...
Status
Not Yet Recruiting
Location
University of California Davis Comprehensive Cancer Center
Start Date
2026-09-01
Trial ID
NCT07759102
This phase II clinical trial studies how well treosulfan, thiotepa, fludara...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2021-05-05
Trial ID
NCT03980769